Respiratory Infection
48
6
6
28
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.2%
2 terminated out of 48 trials
93.3%
+6.8% vs benchmark
13%
6 trials in Phase 3/4
18%
5 of 28 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 28 completed trials
Clinical Trials (48)
Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.
Post Authorization Efficacy and Safety Study (PAES) to Confirm and Collect More Clinical Data of Buccalin® Tablets In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIs).
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia
Analysis of Nasopharyngeal Microbiota in Patients With Respiratory Infections
Continuous Temperature Telemonitoring of Patients With COVID-19 and Other Infectious Diseases in Hospital at Home Using Viture
Nationwide Research on the Rewilding of Kindergarten Yards
Improved Respiratory Infection by Consuming Lactoferrin Fortified a2 Growing up Formula in Children of 2 to 3 Year Old
Impact of High Flow Therapy on Complications Related to Airway Stenting
MeMed BV® Test Evaluation in Adult Emergency Department Patients
Early Diagnosis of Invasive Lung Aspergillosis
Impact of the Use of CRP on the Prescription of Antibiotics in General Practitioners
Effect of IN Hospital PCR Based Assessment of Patients With Lower Respiratory Tract Infections on LEngth of Stay
Netosis in Determination of Respiratory Infection Severity
Vitamin D Level Among Athletes in Uzbekistan
Avoiding Neuromuscular Blockers to Reduce Complications
Clinical Trial to Evaluate the Efficacy and Safety of DWKH
Limiting Adverse Birth Outcomes in Resource-Limited Settings
Association of Inspiratory Muscle Training With HD-tDCS for Assistance to Patients With Long Covid-19
Effectiveness of an Optimal-Massive Intervention in Older Patients With Dysphagia